This difference in mutational status explains the difference in KRAS community scores between pancreatic and ovarian cancers more accurately than cell lineage and stands in contrast to the NF1 gene community example where both a specific lineage and mutational status were important characteristics. The gene discussed is KRAS; the disease is ovarian carcinoma.